Editor's Pick Despite Record Speed, Nanopore Sequencing Faces Challenges for Use in Routine Diagnostics Premium Stanford researchers said the cost of their approach is in line with Illumina sequencing but did not share data on error rate and other benchmarks at this time. SomaLogic's Illumina Codevelopment Deal Suggests Future of Label-Based Proteomics Lies in NGS Premium The assay development deal was "necessary to remain competitive" for SomaLogic, according to MD Anderson proteomics researcher Philip Lorenzi. Sema4 to Embrace Co-CEO Model After $623M Acquisition of GeneDx Premium The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics. Twist Bioscience Sees Demand for New Enzymatic DNA Synthesis Method; Stays Mum on Timeline, Details Premium The South San Francisco-based company claims the new technique is plug-and-play, low cost, scarless, and scalable but said it needs more engineering. Protein-Based Liquid Biopsy Panel Assesses Tumor Microenvironment, Shows Prognostic Potential Premium A panel of 13 circulating proteins related to the tumor microenvironment may provide prognostic clues to prostate cancer progression. Jan 7, 2022 Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom Premium Jan 7, 2022 Genomics, MDx M&A Activity Exploded in 2021 Driven by COVID-19 Testing Tailwinds Jan 7, 2022 International Team Debuts New Platform for DIY Genetic Analysis and Interpretation Premium Jan 5, 2022 Facing Criticism, EHR Vendors Say They're Making Progress in Supporting Genomics Premium Dec 16, 2021 Seven Bridges Genomics to Foster Partnerships Between Health Systems, Pharmas With New Subsidiary Premium Dec 16, 2021 Diagnostic Developers Pursue SARS-CoV-2 Omicron Assays for Surveillance, Potential Clinical Use Premium Dec 16, 2021 Singular Genomics Launches G4 Sequencing Platform Premium Dec 16, 2021 CDC Grants Could Indicate Shift Toward More Federal Funds for Public Health Lab Construction Premium Dec 10, 2021 Long Cell-Free DNA Molecules Could Provide New Target for Noninvasive Prenatal Testing Premium Dec 10, 2021 Linus Biotechnology Looks to Human 'Exposome' as Biomarker for Autism Spectrum Disorders Test Premium Dec 9, 2021 RxPONDER Update Yields No Clear Guidance on Chemo Decisions for Younger Breast Cancer Patients Premium Dec 6, 2021 Helix Study Finds Tie Between HLA Allele, Side Effects of SARS-CoV-2 Vaccines Premium Nov 19, 2021 Most Genetic Counselors Encounter Discrepant Variant Classifications, Must Work Out Interpretations Premium Nov 15, 2021 MiDiagnostics Developing qPCR Platform for SARS-CoV-2 Breath Testing Premium Nov 12, 2021 Meridian Bioscience Looks Beyond COVID-19 for Growth in FY22 Premium Nov 12, 2021 Childhood Brain Tumors in Crosshairs of New CHOP-led Sequencing Biobank Effort Premium Nov 11, 2021 Sysmex Inostics Sees Ultra-Sensitive Leukemia Liquid Biopsy as Potential CDx Premium Nov 10, 2021 Fulgent Genetics Details Diversification, Expansion Strategies Premium Nov 9, 2021 Invitae Unveils Plans to Expand Cancer Testing Portfolio Premium Nov 9, 2021 Harvard, Oxford-Developed Algorithm Uses Evolutionary Data to Predict Disease Variants Premium Load More Breaking News Myasthenia Gravis Study Identifies Genetic Risk Loci Affecting Acetylcholine Receptor Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA Illumina, National Cancer Center Japan Collaborate on Nasopharyngeal Cancer Study Fluidigm Obtains $250M Investment, Changing Name to Standard BioTools SeqOne Genomics Closes €20M Series A Financing NeoGenomics Partners With Biomarker Collaborative to Provide Lung Cancer Resources The Scan For STEM Students to Stay New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports. To Inform or Not, To Know or Not The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information. Rapid Test Studies Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says. PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.